Symptoms of overdose include somnolence, confusion, coma, and diminished reflexes. Respiration, pulse and blood pressure should be monitored.
Ketazolam is a benzodiazepine derivative with anxiolytic, anticonvulsant, sedative and skeletal muscle relaxant activity. Ketazolam is not approved in Canada or America.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Buprenorphine | Ketazolam may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine. |
| Doxylamine | Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Ketazolam. |
| Dronabinol | The serum concentration of Dronabinol can be increased when it is combined with Ketazolam. |
| Droperidol | Droperidol may increase the central nervous system depressant (CNS depressant) activities of Ketazolam. |
| Hydrocodone | Ketazolam may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone. |
| Hydroxyzine | Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Ketazolam. |
| Magnesium sulfate | The therapeutic efficacy of Ketazolam can be increased when used in combination with Magnesium sulfate. |
| Methotrimeprazine | Ketazolam may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine. |
| Metyrosine | Ketazolam may increase the sedative activities of Metyrosine. |
| Minocycline | Minocycline may increase the central nervous system depressant (CNS depressant) activities of Ketazolam. |
| Mirtazapine | Ketazolam may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine. |
| Nabilone | Nabilone may increase the central nervous system depressant (CNS depressant) activities of Ketazolam. |
| Orphenadrine | Ketazolam may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine. |
| Paraldehyde | Ketazolam may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde. |
| Perampanel | Perampanel may increase the central nervous system depressant (CNS depressant) activities of Ketazolam. |
| Pramipexole | Ketazolam may increase the sedative activities of Pramipexole. |
| Ropinirole | Ketazolam may increase the sedative activities of Ropinirole. |
| Rotigotine | Ketazolam may increase the sedative activities of Rotigotine. |
| Rufinamide | The risk or severity of adverse effects can be increased when Rufinamide is combined with Ketazolam. |
| Suvorexant | Ketazolam may increase the central nervous system depressant (CNS depressant) activities of Suvorexant. |
| Tapentadol | Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Ketazolam. |
| Thalidomide | Ketazolam may increase the central nervous system depressant (CNS depressant) activities of Thalidomide. |
| Zolpidem | Ketazolam may increase the central nervous system depressant (CNS depressant) activities of Zolpidem. |
| Clozapine | The risk or severity of adverse effects can be increased when Ketazolam is combined with Clozapine. |
| Methadone | Ketazolam may increase the central nervous system depressant (CNS depressant) activities of Methadone. |
| Sodium oxybate | Ketazolam may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Teduglutide | The serum concentration of Ketazolam can be increased when it is combined with Teduglutide. |
| Yohimbine | The therapeutic efficacy of Ketazolam can be increased when used in combination with Yohimbine. |
| Eliglustat | The metabolism of Eliglustat can be decreased when combined with Ketazolam. |
| Ibrutinib | The metabolism of Ibrutinib can be decreased when combined with Ketazolam. |
| Cilostazol | The metabolism of Cilostazol can be decreased when combined with Ketazolam. |
| Colchicine | The metabolism of Colchicine can be decreased when combined with Ketazolam. |
| Fentanyl | The risk or severity of adverse effects can be increased when Fentanyl is combined with Ketazolam. |
| Iloperidone | The metabolism of Iloperidone can be decreased when combined with Ketazolam. |
| Retapamulin | The metabolism of Retapamulin can be decreased when combined with Ketazolam. |
| Tofacitinib | The metabolism of Tofacitinib can be decreased when combined with Ketazolam. |
| Vardenafil | The metabolism of Vardenafil can be decreased when combined with Ketazolam. |
| Zopiclone | The metabolism of Zopiclone can be decreased when combined with Ketazolam. |
| Lovastatin | The metabolism of Lovastatin can be decreased when combined with Ketazolam. |
| Alfuzosin | The metabolism of Alfuzosin can be decreased when combined with Ketazolam. |
| Alprazolam | The metabolism of Alprazolam can be decreased when combined with Ketazolam. |
| Warfarin | The serum concentration of Warfarin can be increased when it is combined with Ketazolam. |
| Acenocoumarol | The serum concentration of Acenocoumarol can be increased when it is combined with Ketazolam. |
| (R)-warfarin | The serum concentration of (R)-warfarin can be increased when it is combined with Ketazolam. |
| R,S-Warfarin alcohol | The serum concentration of R,S-Warfarin alcohol can be increased when it is combined with Ketazolam. |
| S,R-Warfarin alcohol | The serum concentration of S,R-Warfarin alcohol can be increased when it is combined with Ketazolam. |
| (S)-Warfarin | The serum concentration of (S)-Warfarin can be increased when it is combined with Ketazolam. |
| Midazolam | The serum concentration of Midazolam can be increased when it is combined with Ketazolam. |
| Tacrolimus | The serum concentration of Tacrolimus can be increased when it is combined with Ketazolam. |
| Atorvastatin | The metabolism of Atorvastatin can be decreased when combined with Ketazolam. |
| Ethanol | Ketazolam may increase the central nervous system depressant (CNS depressant) activities of Ethanol. |
| Azelastine | Ketazolam may increase the central nervous system depressant (CNS depressant) activities of Azelastine. |
| Brimonidine | Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Ketazolam. |
| Zimelidine | The risk or severity of adverse effects can be increased when Ketazolam is combined with Zimelidine. |
| Dapoxetine | The risk or severity of adverse effects can be increased when Ketazolam is combined with Dapoxetine. |
| Seproxetine | The risk or severity of adverse effects can be increased when Ketazolam is combined with Seproxetine. |
| Fluvoxamine | The risk or severity of adverse effects can be increased when Ketazolam is combined with Fluvoxamine. |
| Citalopram | The risk or severity of adverse effects can be increased when Ketazolam is combined with Citalopram. |
| Duloxetine | The risk or severity of adverse effects can be increased when Ketazolam is combined with Duloxetine. |
| Trazodone | The risk or severity of adverse effects can be increased when Ketazolam is combined with Trazodone. |
| Paroxetine | The risk or severity of adverse effects can be increased when Ketazolam is combined with Paroxetine. |
| Sertraline | The risk or severity of adverse effects can be increased when Ketazolam is combined with Sertraline. |
| Sibutramine | The risk or severity of adverse effects can be increased when Ketazolam is combined with Sibutramine. |
| Escitalopram | The risk or severity of adverse effects can be increased when Ketazolam is combined with Escitalopram. |
| Milnacipran | The risk or severity of adverse effects can be increased when Ketazolam is combined with Milnacipran. |
| Desvenlafaxine | The risk or severity of adverse effects can be increased when Ketazolam is combined with Desvenlafaxine. |
| Levomilnacipran | The risk or severity of adverse effects can be increased when Ketazolam is combined with Levomilnacipran. |
| Indalpine | The risk or severity of adverse effects can be increased when Ketazolam is combined with Indalpine. |
| Ritanserin | The risk or severity of adverse effects can be increased when Ketazolam is combined with Ritanserin. |
| Alaproclate | The risk or severity of adverse effects can be increased when Ketazolam is combined with Alaproclate. |
| Benzatropine | Benzatropine may decrease the excretion rate of Ketazolam which could result in a higher serum level. |
| Cyproheptadine | The risk or severity of CNS depression can be increased when Cyproheptadine is combined with Ketazolam. |
| Propiomazine | The risk or severity of CNS depression can be increased when Propiomazine is combined with Ketazolam. |
| Propantheline | Propantheline may decrease the excretion rate of Ketazolam which could result in a higher serum level. |
| Dicyclomine | Dicyclomine may decrease the excretion rate of Ketazolam which could result in a higher serum level. |
| Flavoxate | Flavoxate may decrease the excretion rate of Ketazolam which could result in a higher serum level. |
| Aclidinium | Ketazolam may decrease the excretion rate of Aclidinium which could result in a higher serum level. |
| Disopyramide | Disopyramide may decrease the excretion rate of Ketazolam which could result in a higher serum level. |
| Tolterodine | Tolterodine may decrease the excretion rate of Ketazolam which could result in a higher serum level. |
| Tiotropium | Tiotropium may decrease the excretion rate of Ketazolam which could result in a higher serum level. |
| Trimebutine | Ketazolam may decrease the excretion rate of Trimebutine which could result in a higher serum level. |
| Imidafenacin | Ketazolam may decrease the excretion rate of Imidafenacin which could result in a higher serum level. |
| Propiverine | Ketazolam may decrease the excretion rate of Propiverine which could result in a higher serum level. |
| Amitriptyline | The risk or severity of CNS depression can be increased when Amitriptyline is combined with Ketazolam. |
| Imipramine | The risk or severity of CNS depression can be increased when Imipramine is combined with Ketazolam. |
| Nicardipine | The metabolism of Ketazolam can be decreased when combined with Nicardipine. |
| Scopolamine | The risk or severity of CNS depression can be increased when Scopolamine is combined with Ketazolam. |
| Promethazine | The risk or severity of CNS depression can be increased when Promethazine is combined with Ketazolam. |
| Doxepin | The risk or severity of CNS depression can be increased when Doxepin is combined with Ketazolam. |
| Fesoterodine | Ketazolam may decrease the excretion rate of Fesoterodine which could result in a higher serum level. |
| Desipramine | The risk or severity of CNS depression can be increased when Desipramine is combined with Ketazolam. |
| Caffeine | The therapeutic efficacy of Ketazolam can be decreased when used in combination with Caffeine. |
| Dyphylline | The therapeutic efficacy of Ketazolam can be decreased when used in combination with Dyphylline. |
| Pentoxifylline | The therapeutic efficacy of Ketazolam can be decreased when used in combination with Pentoxifylline. |
| Mercaptopurine | The therapeutic efficacy of Ketazolam can be decreased when used in combination with Mercaptopurine. |
| Oxtriphylline | The therapeutic efficacy of Ketazolam can be decreased when used in combination with Oxtriphylline. |
| Theobromine | The therapeutic efficacy of Ketazolam can be decreased when used in combination with Theobromine. |
| Fenethylline | The therapeutic efficacy of Ketazolam can be decreased when used in combination with Fenethylline. |
| 8-azaguanine | The therapeutic efficacy of Ketazolam can be decreased when used in combination with 8-azaguanine. |
| 7,9-Dimethylguanine | The therapeutic efficacy of Ketazolam can be decreased when used in combination with 7,9-Dimethylguanine. |